PyInvesting

Market research

300181.SHE Zhejiang Jolly Pharmaceutical Co.,LTD

SHE CNY Healthcare

Latest close

12 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
9B
P/E ratio
14.14
Analyst target
20
Dividend yield
5.4%
Beta
0.16

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Zhejiang Jolly Pharmaceutical Co.,LTD is currently in a long term uptrend where the price is trading 25.4% above its 200 day moving average.

From a valuation standpoint, the stock is 56.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.2.

Zhejiang Jolly Pharmaceutical Co.,LTD's total revenue rose by 19.0% to $303M since the same quarter in the previous year.

Its net income has increased by 341.6% to $32M since the same quarter in the previous year.

Finally, its free cash flow grew by 56.9% to $108M since the same quarter in the previous year.

Based on the above factors, Zhejiang Jolly Pharmaceutical Co.,LTD gets an overall score of 5/5.